182 related articles for article (PubMed ID: 38692720)
1. Implementation of a primary-tertiary shared care model to improve the detection of familial hypercholesterolaemia (FH): a mixed methods pre-post implementation study protocol.
Birkenhead K; Sullivan D; Trumble C; Spinks C; Srinivasan S; Partington A; Elias L; Hespe CM; Fleming G; Li S; Calder M; Robertson E; Trent R; Sarkies MN
BMJ Open; 2024 May; 14(5):e082699. PubMed ID: 38692720
[TBL] [Abstract][Full Text] [Related]
2. Detection and management of familial hypercholesterolaemia in primary care in Australia: protocol for a pragmatic cluster intervention study with pre-post intervention comparisons.
Arnold-Reed DE; Brett T; Troeung L; Vickery A; Garton-Smith J; Bell D; Pang J; Grace T; Bulsara C; Li I; Bulsara M; Watts GF
BMJ Open; 2017 Oct; 7(10):e017539. PubMed ID: 29061621
[TBL] [Abstract][Full Text] [Related]
3. Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia.
Campbell-Salome G; Jones LK; Masnick MF; Walton NA; Ahmed CD; Buchanan AH; Brangan A; Esplin ED; Kann DG; Ladd IG; Kelly MA; Kindt I; Kirchner HL; McGowan MP; McMinn MN; Morales A; Myers KD; Oetjens MT; Rahm AK; Schmidlen TJ; Sheldon A; Simmons E; Snir M; Strande NT; Walters NL; Wilemon K; Williams MS; Gidding SS; Sturm AC
Circ Genom Precis Med; 2021 Feb; 14(1):e003120. PubMed ID: 33480803
[TBL] [Abstract][Full Text] [Related]
4. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
[TBL] [Abstract][Full Text] [Related]
5. Introducing genetic testing with case finding for familial hypercholesterolaemia in primary care: qualitative study of patient and health professional experience.
Silva L; Condon L; Qureshi N; Dutton B; Weng S; Kai J
Br J Gen Pract; 2022 Jul; 72(720):e519-e527. PubMed ID: 35697509
[TBL] [Abstract][Full Text] [Related]
6. Using implementation science to develop a familial hypercholesterolemia screening program in primary care: The CARE-FH study.
Jones LK; Romagnoli KM; Schubert TJ; Clegg K; Kirchner HL; Hu Y; Cawley D; Norelli V; Williams MS; Gidding SS; Rahm AK
J Clin Lipidol; 2024; 18(2):e176-e188. PubMed ID: 38228467
[TBL] [Abstract][Full Text] [Related]
7. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.
; Vallejo-Vaz AJ; Akram A; Kondapally Seshasai SR; Cole D; Watts GF; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Freiberger T; Abifadel M; Aguilar-Salinas CA; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Ceska R; Corral P; Descamps O; Dieplinger H; Do CT; Durst R; Ezhov MV; Fras Z; Gaita D; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Lin J; Lin N; Maher V; Majano N; Marais AD; März W; Mirrakhimov E; Miserez AR; Mitchenko O; Nawawi H; Nilsson L; Nordestgaard BG; Paragh G; Petrulioniene Z; Pojskic B; Reiner Ž; Sahebkar A; Santos LE; Schunkert H; Shehab A; Slimane MN; Stoll M; Su TC; Susekov A; Tilney M; Tomlinson B; Tselepis AD; Vohnout B; Widén E; Yamashita S; Catapano AL; Ray KK
Atheroscler Suppl; 2016 Dec; 22():1-32. PubMed ID: 27939304
[TBL] [Abstract][Full Text] [Related]
8. Protocol for the implementation of a stepped-care model to address fear of cancer recurrence in patients previously diagnosed with early-stage (0-II) melanoma.
Thompson JR; Smith AL; Lo SN; Kasparian NA; Saw RP; Dieng M; Seaman L; Martin LK; Guitera P; Milne D; Schmid H; Cust AE; Bartula I
BMJ Open; 2022 Mar; 12(3):e054337. PubMed ID: 35241467
[TBL] [Abstract][Full Text] [Related]
9. Screening for familial hypercholesterolaemia in primary school children: protocol for a cross-sectional, feasibility study in Luxembourg city (EARLIE).
Becker M; Adamski A; Fandel F; Vaillant M; Wagner K; Droste DW; Ziade B; Hein S; Mendon P; Bocquet V; de Beaufort C
BMJ Open; 2022 Dec; 12(12):e066067. PubMed ID: 36600332
[TBL] [Abstract][Full Text] [Related]
10. International Atherosclerosis Society Roadmap for Familial Hypercholesterolaemia.
Watts GF; Jones LK; Sarkies MN; Pang J; Gidding SS; Libby P; Santos RD
Glob Heart; 2024; 19(1):12. PubMed ID: 38273993
[TBL] [Abstract][Full Text] [Related]
11. Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part.
Brett T; Qureshi N; Gidding S; Watts GF
Atherosclerosis; 2018 Oct; 277():399-406. PubMed ID: 30270077
[TBL] [Abstract][Full Text] [Related]
12. Optimising the detection and management of familial hypercholesterolaemia: central role of primary care and its integration with specialist services.
Vickery AW; Bell D; Garton-Smith J; Kirke AB; Pang J; Watts GF
Heart Lung Circ; 2014 Dec; 23(12):1158-64. PubMed ID: 25130889
[TBL] [Abstract][Full Text] [Related]
13. Barriers to and Facilitators of Implementing Guidelines for Detecting Familial Hypercholesterolaemia in Australia.
Sarkies MN; Testa L; Best S; Moullin JC; Sullivan D; Bishop W; Kostner K; Clifton P; Hare D; Brett T; Hutchinson K; Black A; Braithwaite J; Nicholls SJ; Kangaharan N; Pang J; Abhayaratna W; Horton A; Watts GF
Heart Lung Circ; 2023 Nov; 32(11):1347-1353. PubMed ID: 37865587
[TBL] [Abstract][Full Text] [Related]
14. Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis.
Qureshi N; Woods B; Neves de Faria R; Saramago Goncalves P; Cox E; Leonardi Bee J; Condon L; Weng S; Akyea RK; Iyen B; Roderick P; Humphries SE; Rowlands W; Watson M; Haralambos K; Kenny R; Datta D; Miedzybrodzka Z; Byrne C; Kai J
Health Technol Assess; 2023 Oct; 27(16):1-140. PubMed ID: 37924278
[TBL] [Abstract][Full Text] [Related]
15. Familial hypercholesterolaemia: a study protocol for identification and investigation of potential causes and markers of subclinical coronary artery disease in the Faroe Islands.
Borg SÁ; Nielsen MRS; Søgaard P; Lundbye-Christensen S; Jóanesarson J; Zaremba T; Kollslíð R; Schmidt EB; Joensen AM; Bork CS
BMJ Open; 2022 Apr; 12(4):e050857. PubMed ID: 35414540
[TBL] [Abstract][Full Text] [Related]
16. Case-finding and genetic testing for familial hypercholesterolaemia in primary care.
Qureshi N; Akyea RK; Dutton B; Humphries SE; Abdul Hamid H; Condon L; Weng SF; Kai J;
Heart; 2021 Dec; 107(24):1956-1961. PubMed ID: 34521694
[TBL] [Abstract][Full Text] [Related]
17. Systematic detection of familial hypercholesterolaemia in primary health care: a community based prospective study of three methods.
Kirke AB; Barbour RA; Burrows S; Bell DA; Vickery AW; Emery J; Watts GF
Heart Lung Circ; 2015 Mar; 24(3):250-6. PubMed ID: 25445428
[TBL] [Abstract][Full Text] [Related]
18. Impact of genetic testing on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia (GenTLe-FH): a randomised waiting list controlled open-label study protocol.
Nomura A; Tada H; Okada H; Nohara A; Ishikawa H; Yoshimura K; Kawashiri MA
BMJ Open; 2018 Dec; 8(12):e023636. PubMed ID: 30593551
[TBL] [Abstract][Full Text] [Related]
19. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL
Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
[TBL] [Abstract][Full Text] [Related]
20. Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia.
Watts GF; Sullivan DR; Hare DL; Kostner KM; Horton AE; Bell DA; Brett T; Trent RJ; Poplawski NK; Martin AC; Srinivasan S; Justo RN; Chow CK; Pang J;
Heart Lung Circ; 2021 Mar; 30(3):324-349. PubMed ID: 33309206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
